Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)

NCT03019419 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

ALS

Interventions

DRUG: Perampanel
DRUG: placebo

Sponsor

Tokyo Medical University